ANATOMIC PATTERNS OF RELAPSE AND PROGRESSION FOLLOWING TREATMENT WITH 131I-MIBG IN METASTATIC NEUROBLASTOMA

被引：0
|
作者：
Ben Kenan, Fishel R. [1 ,2 ]
Polishchuk, A. [2 ]
Haas-Kogan, D. [2 ]
机构：
[1] UA COM Phoenix, Phoenix, AZ USA
[2] UCSF, San Francisco, CA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2017年 / 65卷 / 01期
关键词：
D O I：
10.1136/jim-2016-000365.104
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
104
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [1] Anatomic Patterns of Relapse and Progression Following Treatment With 131I-MIBG in Metastatic Neuroblastoma
    Ben Kenan, R. Fishel
    Polishchuk, A. L.
    Hawkins, R. A.
    Braunstein, S. E.
    Matthay, K. K.
    DuBois, S. G.
    Haas-Kogan, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S196 - S196
  • [2] Anatomic patterns of relapse and progression following treatment with 131I-MIBG in relapsed or refractory neuroblastoma
    Ben Kenan, Rotem Fishel
    Polishchuk, Alexei L.
    Hawkins, Randall A.
    Braunstein, Steve E.
    Matthay, Katherine K.
    DuBois, Steven G.
    Haas-Kogan, Daphne A.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (02)
  • [3] Biomarker Modulations in Children With Neuroblastoma Following Treatment With 131I-mIBG
    Imber, B. S.
    Olow, A.
    Karski, E. E.
    Allen, I. E.
    DuBois, S. G.
    Haas-Kogan, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S729 - S730
  • [4] Dosimetry for therapeutic treatment of neuroblastoma by 131I-mIBG
    Sudbrock, F.
    Eschner, W.
    Schmidt, M.
    Simon, T.
    Hero, B.
    Schicha, H.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2006, 45 (06): : 254 - 261
  • [5] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Simon, Thorsten
    Eschner, Wolfgang
    Berthold, Frank
    Schicha, Harald
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1279 - 1290
  • [6] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Ferdinand Sudbrock
    Matthias Schmidt
    Thorsten Simon
    Wolfgang Eschner
    Frank Berthold
    Harald Schicha
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1279 - 1290
  • [7] 131I-MIBG treatment in patients with metastatic paraganglioma and pheocrhomocytoma
    Bernal, J.
    Prado, S.
    Agudelo, M.
    Utrera, A.
    Canon, J.
    Bello, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S690 - S690
  • [8] The Role of 131I-MIBG in High-Risk Neuroblastoma Treatment
    Lessig, Megan Kinnear
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2009, 26 (04) : 208 - 216
  • [9] Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma
    Anongpornjossakul, Yoch
    Sriwatcharin, Wattanun
    Thamnirat, Kanungnij
    Chamroonrat, Wichana
    Kositwattanarerk, Arpakorn
    Utamakul, Chirawat
    Sritara, Chanika
    Chokesuwattanasakul, Payap
    Thokanit, Nintita Sripaiboonkij
    Pakakasama, Samart
    Anurathapan, Usanarat
    Pongphitcha, Pongpak
    Chotipanich, Chanisa
    Hongeng, Suradej
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (04) : 336 - 343
  • [10] Is there a benefit of 131I-MIBG therapy FOR in the treatment of children with stage 4 neuroblastoma?
    Schmidt, M.
    Simon, T.
    Hero, B.
    Eschner, W.
    Dietlein, M.
    Sudbrock, F.
    Bongartz, R.
    Berthold, F.
    Schicha, H.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2006, 45 (04): : 145 - 151
12345